Form 4 · Filed Jun 29, 2026, 08:20 PM UTC
ARTV/Artiva Biotherapeutics, Inc.
RA CAPITAL MANAGEMENT, L.P. — director
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
2 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 26, 2026 | P | buy | 1,876 | $9 | $16,846 | 16,795,919 |
| Jun 25, 2026 | P | buy | 31,000 | $9 | $275,280 | 16,794,043 |
Source: SEC EDGAR raw filing ↗ · Accession 0001231919-26-000711